Femasys Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FEMY research report →
Price Chart
About the company
Femasys Inc. , a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering.
- CEO
- Kathy Lee-Sepsick
- IPO
- 2021
- Employees
- 53
- HQ
- Suwanee, GA, US
Get TickerSpark's AI analysis on FEMY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.09M
- P/E
- -0.59
- Fwd P/E
- 1.18
- PEG
- -0.00
- P/S
- 3.52
- P/B
- 2.23
- EV/EBITDA
- -1.17
- Div Yield
- 0.00%
- Gross Margin
- 52.16%
- Op Margin
- -763.90%
- Net Margin
- -534.27%
- ROE
- -225.98%
- ROIC
- -197.91%
Latest fiscal year · YoY change
- Revenue
- $2.29M+40.8%
- Gross Profit
- $1.42M+31.1%
- Op Income
- $-17,588,669
- Net Income
- $-18,627,887+1.0%
- EPS
- $-9.40+44.0%
- OCF Growth
- +3.9%
- FCF Growth
- +4.9%
- 52W High
- $22.20
- 52W Low
- $2.02
- 50D MA
- $3.18
- 200D MA
- $8.75
- Beta
- -2.07
- RSI (14)
- 43
- Avg Volume
- 741.20K
No earnings-call transcripts are available for FEMY yet.
- Free Float
- 82.6%
- Shares Outstanding
- 3.02M
- Float Shares
- 2.50M
of shares held by institutions
36 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 1.42M | ▲ 463.69K |
| Pandora Wealth, Inc. | 15.00K | 0 |
| Gibbs Wealth Management | 12.10K | ▲ 12.10K |
| Ifp Advisors, Inc | 1.00K | 0 |
| Cx Institutional | 750 | ▼ 14.25K |
Held by 21 ETFs
Biggest fund positions in FEMY by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 24, 26 | Eichenbaum Kenneth D. | other | 880 |
| Jun 24, 26 | Uzialko Edward R | other | 880 |
| Jun 24, 26 | Milnes Alistair | other | 880 |
| Jun 24, 26 | Larsen Charles | other | 880 |
| Aug 7, 26 | Mifek Jeffrey Gerald | buy | 3,125 |
| Aug 7, 26 | Mifek Jeffrey Gerald | other | 3,125 |
| Aug 7, 26 | Mifek Jeffrey Gerald | other | 3,125 |
| Jul 6, 26 | Mifek Jeffrey Gerald | other | 6,250 |
| Jul 6, 26 | Mifek Jeffrey Gerald | other | 0 |
| Aug 7, 26 | Sipos Jeremy Alexander | buy | 3,125 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FEMY coverage
Recent articles, reports, and earnings notes.
No research on FEMY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FEMY report →Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
globenewswire.com · Aug 26
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
benzinga.com · Aug 19
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
globenewswire.com · Aug 14
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
globenewswire.com · Aug 12
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
globenewswire.com · Aug 7
Femasys Regains Compliance with Nasdaq Listing Requirements
globenewswire.com · Jun 24
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
globenewswire.com · May 13
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
globenewswire.com · May 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.